The Financial Firepower Gap: Mercedes' Balance Sheet vs the Claimant Funding Machine

Who can afford to fight — and who pays for the fight either way

Written by Will Whawell. Human intelligence throughout; AI assisted with the drafting.

July 2026

Mercedes-Benz Group generated €132.2 billion in revenue in 2025 — roughly €2.5 billion a week, on my arithmetic — and still produced €5.4 billion of free cash flow from its industrial business in a year of tariffs, currency headwinds and Chinese competition. It closed the year on €32.2 billion of net industrial liquidity. The major rating agencies place the group in the "A" band, which is why its bonds price at investment-grade yields. That is the cost of money for the lead defendant that just prevailed in the Pan-NOx Emissions Group Litigation

Now look at the other side of the table. The claimant ecosystem in mass consumer litigation — funders, disbursement lenders, claims managers — typically pays far more for capital. Published market rates tell the story: law-firm disbursement funding at around 10% a year compounding monthly; client-facing litigation loans in the mid-teens to mid-twenties; loan interest north of 30% has been litigated in open court; and commercial litigation funders target — and the largest have historically realised — internal rates of return in the 25–35% range. These are indicative figures drawn from lender and industry publications rather than a single authoritative dataset, but the order of magnitude is not in serious dispute — and at the top of the market it is worse: in my experience of funded consumer matters, funder returns can run as high as 60% of the sums funded. Nor is that cost always visible to the people the claim is for. In these waves the funder's return is commonly carried through the law firm's own fee arrangements — the CFA or DBA that sets out who takes what — rather than appearing as a clean deduction from the client's damages, which means the true cost of the capital financing a claim can be decidedly opaque to the client it is financing. Either way, the arithmetic holds: the claimant side's capital costs run at roughly five to ten times the defendant's, and the difference compounds every month a case runs.

That asymmetry does not decide legal questions. It decides how long each side can afford to fight, and it shapes which cases get brought, settled or dropped before a judge ever rules on the merits. Pan-NOx illustrates the dynamic well: throughout its case-management phases the High Court repeatedly scrutinised claimant funding arrangements and the adequacy of after-the-event cover, and the Civil Justice Council's June 2025 Final Report took the commercial realities of funder-backed mass claims as its starting point.

The regulatory reset is under way — but money will not get cheaper

Three developments frame where this goes next. The CJC's June 2025 report recommended a light-touch statutory regime for funders and deliberately declined to cap funder returns, preferring court assessment of whether a funder's return is "fair, just and reasonable" in collective proceedings. In July 2025 the Court of Appeal held that funding agreements remunerated as a multiple of invested capital are not damages-based agreements — removing a PACCAR-shaped cloud over the standard funding model. And in December 2025 the government committed to legislate to reverse the effect of PACCAR itself. Transparency is coming; cheaper capital is not.

Why this matters well beyond Pan-NOx

The same funding gap is playing out at far higher volume in the FCA's motor finance redress scheme. The regulator's final rules (PS26/3, March 2026) anticipate around £7.5 billion of redress across roughly 12.1 million agreements — an average of about £829 per agreement at the FCA's assumed take-up. Claims management companies have piled in, charging substantial percentages of payouts that consumers can obtain for free through the scheme.

The stakes are not theoretical. On 17 July 2026 Woodville Consultants — a Pontypridd litigation-funding business with a loan book of around £250 million behind roughly 300,000 claims, many tied to the car finance wave — entered administration, with Kroll appointed and thousands of loan-note investors, promised returns of up to 12%, left exposed. It has nothing to do with Pan-NOx, but it is a live indicator of how fragile the high-cost end of the claimant funding ecosystem can be — and of who is left carrying the risk when a funder's own funding model fails.

The regulator has noticed. In May 2026 the FCA launched a formal market study into claims management services, examining whether consumers get fair value and existing price caps remain appropriate; whether financial incentives — fee structures, funding and insurance arrangements — create conflicts of interest that drive poor conduct; and whether the end-to-end consumer journey delivers good outcomes. A joint FCA–SRA taskforce has already secured the removal of some 800 misleading motor finance adverts, helped more than 28,000 consumers exit CMC contracts without fees, and pressed three claims managers into fee reductions protecting over half a million consumers.

Put the two pictures side by side. On one side of the litigation and redress landscape sits an A-rated defendant borrowing at single-digit rates against tens of billions in liquidity. On the other sits a claimant infrastructure borrowing at 10% to 30%-plus and passing a chunk of that cost straight through to the people the system is supposed to compensate. Until the funding arithmetic changes, the side with the cheaper balance sheet will keep winning the war of attrition — whatever the merits.

Figures current as of July 2026; the FCA's claims management market study and the Pan-NOx October 2026 remedies hearing are both live and will move some of these numbers. Funding-cost ranges are indicative market figures from lender and industry publications.